To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Kennedy vowed to “Make America Healthy Again,” has delivered an inconsistent message that has the nation’s top infectious ...

A first of its kind surgery to help people with a specific type of heart failure is going through clinical trials at Providence St. Vincent’s.

An Australian man in his forties has become the first person in the world to leave hospital with an artificial heart made of ...

Dyne Therapeutics’ DYNE-101 shows positive results in phase 1/2 ACHIEVE study. Read why DYN stock may rise with FDA approval and a $2.78B market opportunity.

It’s been just six months since Zevra Therapeutics scored an FD | Niemann-Pick disease type C therapy Miplyffa became ...

Ozempic and other similar drugs must be injected. Messer describes the needle as “small, the size of two human hairs.” ...

Dr. Chandler Park sat down for an interview with CURE® to discuss the biggest takeaway from the 2025 ASCO GU Symposium in ...

Analysts expect Sun to continue to be more aggressive in chasing speciality assets, but a successful launch is necessary for ...

Propranolol and metoprolol are beta-blockers taking to treat certain heart conditions. Learn more about their similarities ...

Recent developments in the skincare industry have raised concerns over the safety of certain acne treatment products. The U.S. Food and Drug Administration (FDA) issued a recall alert on March 11, ...

On an August morning in 1949, when I was six, I got out of bed and collapsed on the floor. By evening, I was paralyzed from the neck down and in an iron lung. I spent the next five months in a polio ...